What is the long-term trend for Castle Biosciences's accrued bonuses current and noncurrent?

Over 5 years (2020 to 2025), Castle Biosciences's accrued bonuses current and noncurrent has grown at a 31.4% compound annual growth rate (CAGR), from $7.18M to $28.1M.

Castle Biosciences CSTL Accrued Bonuses Current And Noncurrent

Accrued Bonuses Current And Noncurrent at other companies

Nuvation BioNUVB

$3.98M-3.3%

Evommune EVMN

$293.33K—

Burford CapitalBUR

$85.29M-56.8%

Steven MaddenSHOO

$6.92M+161%

Relmada Therapeutics, Inc.RLMD

$516.3K+12.9%

ADMA BiologicsADMA

$1.74M+3.9%

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:AccruedBonusesCurrentAndNoncurrent.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's accrued bonuses current and noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's accrued bonuses current and noncurrent?: Castle Biosciences (CSTL) reported accrued bonuses current and noncurrent of $7.9M in Q1 2026.
How has Castle Biosciences's accrued bonuses current and noncurrent changed year-over-year?: Castle Biosciences's accrued bonuses current and noncurrent increased by 3.9% year-over-year, from $7.6M to $7.9M.
What is the long-term trend for Castle Biosciences's accrued bonuses current and noncurrent?: Over 5 years (2020 to 2025), Castle Biosciences's accrued bonuses current and noncurrent has grown at a 31.4% compound annual growth rate (CAGR), from $7.18M to $28.1M.